
PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW146171 |
drug action
Cetyl alcohol Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:34 Last Updated: October 07, 2023 at 17:34 |
PW146215 |
drug action
Cetylpyridinium Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:41 Last Updated: October 07, 2023 at 17:41 |
PW144316 |
drug action
Cevimeline Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:22 Last Updated: October 07, 2023 at 13:22 |
PW128284 |
drug action
Cevimeline M1 Saliva Excretion Action PathwayHomo sapiens
Cevimeline is a muscarinic agonist with parasympathomimetic activities that is used for the symptomatic treatment of dry mouth in patients with Sjögren's Syndrome. It is administered as an oral tablet and can be found under the brand name Evoxac. Cevimeline is a parasympathomimetic agent that act as an agonist at the muscarinic acetylcholine receptors M1 and M3. Muscarinic agonists in sufficient dosage can increase secretion of exocrine glands, such as salivary and sweat glands and increase tone of the smooth muscle in the gastrointestinal and urinary tracts. The M1 receptors are common in secretory glands (exocrine glands such as salivary and sweat glands), and their activation results in an increase in secretion from the secretory glands. Therefore, as saliva excretion is increased, the symptoms of dry mouth are relieved.
|
Creator: Hayley Created On: August 15, 2023 at 12:49 Last Updated: August 15, 2023 at 12:49 |
PW128285 |
drug action
Cevimeline M3 Salivary Gland Smooth Muscle Contraction Action PathwayHomo sapiens
Cevimeline is a muscarinic agonist with parasympathomimetic activities that is used for the symptomatic treatment of dry mouth in patients with Sjögren's Syndrome. It can be found under the brand name Evoxac. Cevimeline is a parasympathomimetic agent that act as an agonist at the muscarinic acetylcholine receptors M1 and M3. Muscarinic agonists such as cevimeline bind and activate the muscarinic M1 and M3 receptors. The M1 receptors are common in secretory glands (exocrine glands such as salivary and sweat glands), and their activation results in an increase in secretion from the secretory glands. The M3 receptors are found on smooth muscles and in many glands which help to stimulate secretion in salivary glands, and their activation generally results in smooth muscle contraction and increased glandular secretions. Therefore, as saliva excretion is increased, the symptoms of dry mouth are relieved. Salivary secretion is largely dependent upon the activation of acinar cell fluid transport, achieved through intracellular formation of inositol triphosphate and elevated calcium concentration and activation of ion transporting proteins. Sustained salivary secretion requires influx of extracellular calcium across the plasma membrane of acinar cells, which is referred to as store-operated calcium entry. Possible side effects of using Civimeline may include bladder pain, body aches, and difficulty breathing.
|
Creator: Hayley Created On: August 15, 2023 at 13:03 Last Updated: August 15, 2023 at 13:03 |
PW122269 |
physiological
charlieHomo sapiens
|
Creator: Guest: Anonymous Created On: October 27, 2018 at 13:13 Last Updated: October 27, 2018 at 13:13 |
PW292651 |
physiological
Chemotaxis operon activationPseudomonas sp.
The chemotaxis operon is crucial for the bacterium's ability to sense and respond to environmental signals, which is vital for its motility and pathogenicity. This operon consists of cheW2, orf566, cheA1, cheB2, orf569 and cheY2 genes and is located about 400kb from the flaB operon. cheW2 encodes a coupling protein that is involved in chemotaxis, facilitating interactions between sensory proteins and response regulators. The functions of orf566 and orf569 genes are not well defined but has been found to be an open reading frame. cheA1 encodes a histidine kinase that acts as a sensor in the chemotaxis signaling pathway, initiating the response to environmental signals. cheB2 encodes a methylesterase involved in modification of sensory proteins. cheY2 encodes a response regulator that interacts with the flagellar motor to influence the direction of movement based on the chemotactic signals.
|
Creator: Julia Wakoli Created On: September 03, 2024 at 15:15 Last Updated: September 03, 2024 at 15:15 |
PW145785 |
drug action
Chenodeoxycholic acid Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:39 Last Updated: October 07, 2023 at 16:39 |
PW127201 |
disease
CHILD SyndromeHomo sapiens
CHILD Syndrome, (Congenital Hemidysplasia with Icthyosiform Erythroderma and Limb Defects; Ichthyosiform Eruthroderma, Unilateral, with Epsilateral Malformations, Especially Absence Deformity of Limbs) is caused by a mutation in the gene encoding NADH steroid dehydrogenase-like protein (NSDHL). A defect in sterol-4 alpha-carboxylate 3-dehydrogenase, which normally catalyzes the reaction 3-beta-hydroxy-4-beta-methyl-5-alpha-cholest-7-ene-4-alpha-carboxylate + NAD+ = 4-alpha-methyl-5-alpha-cholest-7-en-3-one + CO2 + NADH, causes accumulation of 8(9)cholestenol and 8-dehydrocholesterol in plasma. Symptoms of CHILD syndrome include hearing defects, hemidysplasia, unilateral hypomelia, ichthyosiform nevi, limb abnormalities, lung hypoplasia, and punctate calcifications.
|
Creator: Ray Kruger Created On: November 08, 2022 at 08:57 Last Updated: November 08, 2022 at 08:57 |
PW121715 |
disease
CHILD SyndromeMus musculus
CHILD Syndrome, (Congenital Hemidysplasia with Icthyosiform Erythroderma and Limb Defects; Ichthyosiform Eruthroderma, Unilateral, with Epsilateral Malformations, Especially Absence Deformity of Limbs) is caused by a mutation in the gene encoding NADH steroid dehydrogenase-like protein (NSDHL). A defect in sterol-4 alpha-carboxylate 3-dehydrogenase, which normally catalyzes the reaction 3-beta-hydroxy-4-beta-methyl-5-alpha-cholest-7-ene-4-alpha-carboxylate + NAD+ = 4-alpha-methyl-5-alpha-cholest-7-en-3-one + CO2 + NADH, causes accumulation of 8(9)cholestenol and 8-dehydrocholesterol in plasma. Symptoms of CHILD syndrome include hearing defects, hemidysplasia, unilateral hypomelia, ichthyosiform nevi, limb abnormalities, lung hypoplasia, and punctate calcifications.
|
Creator: Ana Marcu Created On: September 10, 2018 at 15:49 Last Updated: September 10, 2018 at 15:49 |